Journals / Acta Medica Alanya / 2019 / Cilt: 3 - Sayı: 1

Prevalence of Chronic Kidney Disease and Hyperuricemia In Gout Arthritis Patients

Gut Artritli Hastalarda Hiperürisemi ve Kronik Böbrek Hastalığının Prevalansı

Pages
54–58
Publication Date
2022-09-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Similar to otherstudies in our study, the prevalence of CKD in gout arthritis was found high.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study is to determine the prevalence of Chronic renal disease(CKD) in the patients known with gout arthritis.Method:A total of 162 patients with gout arthritis diagnosed between 2014 and 2017were included in the study.
📊
Key Findings & Data:Glomerular filtration ratewas calculated by Modification of Renal Disease (MDRD) method.Results: The mean age of the patients was found as 59,64 ± 14,54 (18-93).
💡
Conclusion & Impact:Similar to otherstudies in our study, the prevalence of CKD in gout arthritis was found high.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study is to determine the prevalence of Chronic renal disease(CKD) in the patients known with gout arthritis.Method:A total of 162 patients with gout arthritis diagnosed between 2014 and 2017were included in the study. Our work is a retrospective study. Glomerular filtration ratewas calculated by Modification of Renal Disease (MDRD) method.Results: The mean age of the patients was found as 59,64 ± 14,54 (18-93). Themajority of patients are male. Mean uric acid levels of the patients were found to be9.07 mg / dL ± 1.75 (4-14.7). Among these individuals with gout arthritis, % 39,5 (64)had CKD stage 3-5, %46,9 (76) had hypertension, %18,5 (30) had diabetes mellitus,%14,2 (23) had coronary artery disease. 33.3% of the patients had CKD stage 2.Nephrolithiasis was detected in 22 of 85 ultrasound patients. The use of diureticswas detected in 36 of the patients. The consultation rate requested by the dieticianwas 41,4%.Conclusions: Hyperuricemia and hypertension are high in CKD. Diuretics used inthe treatment of hypertension and edema may trigger gout arthritis. Similar to otherstudies in our study, the prevalence of CKD in gout arthritis was found high.

Özet

Amaç: Bu çalışmanın amacı, gut artriti tanısı konan hastalarda kronik böbrek hastalığı (KBH) prevalansını saptamaktır. Yöntem: Bu çalışmaya 2014 ile 2017 tarihleri arasında gut artirti tanısı konan toplam 162 hasta alındı. Çalışmamız retrospektif bir çalışmadır. Glomeruler filtrasyon hızı Modification of Renal Disease (MDRD) yöntemiyle hesaplandı. Bulgular: Hastaların yaş ortalaması 59,64±14,54 (18-93) olarak bulundu. Hastaların çoğunluğu erkekti. Hastaların ortalama ürik asit seviyeleri 9,07mg/dl±1,75(4-14,7) olarak bulundu. Gut artritli bireylerin % 39,5'i (64) KBH evre 3-5, % 46.9’u (46) hipertansiyon, % 18,5 (30) diabetes mellitus, % 14,2’sinde (23) koroner arter hastalığı mevcuttu. Hastaların %33,3'ü CKD evre 2 olarak saptandı. Ultrasonu yapılmış 85 hastanın 22'sinde nefrolitiyazis vardı. Hastaların 36'sında diüretik kullanımı tespit edildi. Diyetisyenden istenilen konsültasyon oranı %41,4 idi. Sonuçlar: KBH’de hiperürisemi ve hipertansiyon sıklığı yüksektir. Hipertansiyon ve ödem tedavisinde kullanılan diüretikler gut hastalığını tetikleyebilir. Yaptığımız çalışmada diğer çalışmalara benzer şekilde, gut artritli hastalarda CKD prevalansı yüksek oranda saptandı.

🔖

Cite This Article

TİMUÇİN, M., HÜZMELİ, C., GÜLLÜ, M., CANDAN, F., ÖZTÜRK, K., YETİMOĞLU, E. (2022). Prevalence of Chronic Kidney Disease and Hyperuricemia In Gout Arthritis Patients. Acta Medica Alanya, Cilt: 3 - Sayı: 1, 54–58. https://ajindex.com/articles/425887

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Kuo CF, Grainge MJ, Mallen C, et al. Eligibility for and prescrip¬tion of urate lowering treatment in patients with incident gout in England. JAMA. 2014
  2. PMID: 25536262 2. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011
  3. 3136–41. PMID: 21800283 3. Kawasaki T, Shichikawa K. Epidemiology survey of gout using residents’ health checks. Gout Nucleic Acid Metabo, 2006
  4. Pisaniello HL, Lester S, Gonzalez-Chia D et al. Gout prevalence and predictors of urate-lowering therapy use: results from a popula¬tion-based study. Research & Therapy 2018
  5. PMID: 29996922 5. Chuang SY, Chen JH, Yeh WT, Wu CC, Pan WH. Hyperuricemia and increased risk of ischemic heart disease in a large Chinese co¬hort. Int J Cardiol. 2012
  6. 154(3):316–21. PMID: 21862159 6. Chandratre P, Roddy E, Clarson L et al. Health related quality of life in gout: a systematic review. Rheumatology (Oxford). 2013
  7. 52(11):2031-40. PMID: 23934311 7. Punzi L, Scanu A, Spinella P, Galozzi P, Oliviero F. One year in review 2018: gout. Clin Exp Rheumatol. 2019
  8. 37(1):1-11. PMID: 30620275 8. Delanaye T, Glassock RJ, De Broe ME. Epidemiology of chron¬ic kidney disease:think (at least) twice Clinical Kidney Journal. 2017
  9. 10( 3): 370–4. https://doi.org/10.1093/ckj/ sfw154 9. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease Kidney International Supplements. 2013
  10. 91–111. doi:10.1038/ kisup.2012.67 10. Johnson RJ. Why focus on uric acid? Curr Med Res Opin.2015
  11. 31(suppl 2):3-7. PMID: 26414730 11. Lin KC, Lin H Y & Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J. Rheumatol. 2000
  12. 1501–5. PMID: 10852278 12. Zalokar J, Lellouch J, Claude JR. & Kuntz D. Serum uric acid in 23,923 men and gout in a subsample of 4,257 men in France. J Chronic Dis. 1972
  13. 25,:305–12. PMID: 4639928 13. Krishnan E. Reduced glomerular function and prevalence of gout: NHANES 2009–10. PLoS One. 2012
  14. e50046. PMID: 23209642 14. Juraschek SP, Kovell LC, Miller ER 3rd, Gelber AC. Association of kidney disease with prevalent gout in the United States in 1988–1994 and 2007–2010.Semin Arthritis Rheum. 2013
  15. 42(6):551-61. PMID: 23312548 15. Ohno I, Ichida K, Okabe H, Hikita M, Uetake D, Kimura H, Saikawa H, Hosoya T. Frequency of gouty a